患有血液性恶性瘤的患者的症状负担和息护理:单中心体验
Annasofia Holopainen1,2, Taru Kuittinen3, Kristiina Tyynelä-Korhonen4
1Department of Hematology, Kuopio University Hospital, The Wellbeing Services County of North Savo, Kuopio, Finland. Annasofia.holopainen@pshyvinvointialue.fi.
概括
患有血液性恶性瘤的患者经历了显著的症状负担,需要广泛的息治疗,特别是在临终期. 早期的息护理整合对于管理不同诊断的疲劳,疼痛和呼吸障碍等症状至关重要.
科学领域:
- 血液学 血液学 血液学
- 抚慰性护理是一种缓解性护理.
- 在瘤学瘤学.
背景情况:
- 血液性恶性瘤由于显著的症状负担和急诊室访问和住院的高率而存在复杂的息护理需求.
- 关于不同血液恶性瘤诊断组的症状负担和医疗保健服务利用情况的数据有限.
研究的目的:
- 描述患有血液性恶性瘤的患者的症状负担和息护理阶段.
- 在不同的诊断群体中分析这些特征:骨髓瘤,淋巴瘤,白血病和骨髓质疏松症候群或骨髓增殖性新生体 (MDS/MPN).
主要方法:
- 在2015年至2023年期间死亡的195名患有血液性恶性瘤的患者的回顾性研究.
- 患者被分为四个诊断组:髓瘤,淋巴瘤,白血病和MDS/MPN.
- 收集了关于症状负担和息治疗利用率的数据.
主要成果:
- 所有患者群体都表现出大量的症状负担,频繁的急诊室访问和临终临近的住院.
- 息护理的参与往往是在疾病发展轨迹晚期开始的.
- 常见的症状包括疲劳,疼痛,呼吸障碍,食欲丧失,抑郁和焦虑,根据诊断组而异.
结论:
- 患有血液性恶性瘤的患者面临着显著的症状负担,并且在生命末期需要大量的息护理.
- 提高对早期息护理整合益处的认识和研究是必不可少的.
- 针对不同的血液性恶性瘤亚型,可能需要量身定制的息护理方法.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Continuing Care
2.0K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.0K
Bone Marrow Sampling and Transplants
1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K

